| Patient | Florence Nightingale |
|---|---|
| Date of birth | 1988-05-12 |
| Identifiers | MRN HR-NI004-SYN; SSN (made up) 000-04-9271 |
| Document date | 2026-06-01 |
| Author | Isobel Marchetti, MD |
| Custodian | St. Posthumous Health Center |
Readable copy of the C-CDA narrative, generated with the XML. Coded entries are in the XML file beside this page.
Three-month ME/CFS energy management review. [S]
Ms. Nightingale returns for her ME/CFS review eleven weeks after the diagnosis. She has had three sessions with the occupational therapist and now works in 30- to 45-minute blocks with lying-down rests between them, stopping before she feels spent. Her diary shows two crashes in the past two months, each after a day she broke the plan to meet a deadline, compared with one or two a week before. She drinks about 2.2 L a day, salts her meals, and wears compression garments; she is lightheaded on standing two or three times a week rather than daily. She still wakes unrefreshed but less heavy. Muscle aches are milder and she takes acetaminophen about once a week. She takes cholecalciferol every day. She wants to add an hour of work a day. [S]
| Element | Detail |
|---|---|
| Interval change | Two crashes in two months, down from one or two a week |
| Energy management | Work in 30- to 45-minute blocks with rests; three occupational therapist sessions |
| Orthostatic symptoms | Two or three times a week, down from daily |
| Sleep | Still unrefreshing but improved |
| Pain | Milder; acetaminophen about once a week |
| Patient goal | Add an hour of work a day |
| System | Result | Finding |
|---|---|---|
| Constitutional | Positive | Fatigue improved; no fever, night sweats, or weight loss |
| Cardiovascular | Positive | Occasional lightheadedness on standing; no syncope |
| Musculoskeletal | Positive | Milder diffuse aches; no focal back or joint pain |
| Neurological | Positive | Concentration better within her work blocks |
| Psychiatric | Negative | Mood steady; PHQ-9 score 6 with item 9 scored 0 |
5 systems reviewed. [S]
| Medication | Frequency | Route | Dates | Status | Evidence |
|---|---|---|---|---|---|
| Acetaminophen 500 mg oral tablet, one to two tablets by mouth every 6 hours as needed for muscle pain or headache, no more than 3 g a day | One to two tablets by mouth every 6 hours as needed; no more than 3 g a day | Oral route | 2025-11-03 | active | S |
| Cholecalciferol (vitamin D3) 50 mcg (2,000 units) oral tablet, one tablet by mouth daily | One tablet by mouth daily | Oral route | 2026-03-16 | active | S |
| Allergy | Reaction | Status | Evidence |
|---|---|---|---|
| No known allergy | active | S |
| Date | Measure | Value | Unit | Provenance |
|---|---|---|---|---|
| 2026-06-01 | Body height | 170 | cm | S |
| 2026-06-01 | Body weight | 55.6 | kg | S |
| 2026-06-01 | Body mass index (BMI) [Ratio] | 19.2 | kg/m2 | S |
| 2026-06-01 | Systolic blood pressure | 108 | mm[Hg] | S |
| 2026-06-01 | Diastolic blood pressure | 68 | mm[Hg] | S |
| 2026-06-01 | Heart rate | 74 | /min | S |
| 2026-06-01 | Respiratory rate | 14 | /min | S |
| 2026-06-01 | Body temperature | 36.6 | Cel | S |
| 2026-06-01 | Oxygen saturation in Arterial blood by Pulse oximetry | 99 | % | S |
| Date | Measure | Value | Unit | Reference range | Flag | Provenance |
|---|---|---|---|---|---|---|
| 2026-06-01 | Patient Health Questionnaire 9 item (PHQ-9) total score [Reported] | 6 | {score} | S | ||
| 2026-06-01 | PROMIS fatigue - version 1.0 Tscore | 67 | {score} | S | ||
| 2026-06-01 | PROMIS physical function - version 1.0 Tscore | 35 | {score} | S | ||
| 2026-06-01 | Pain severity - 0-10 verbal numeric rating [Score] - Reported | 3 | {score} | S |
Vital signs recorded on 2026-06-01; see the Vital Signs section. [S]
| System | Finding |
|---|---|
| General | Alert and engaged; sits upright for most of the visit |
| Cardiovascular | Regular rhythm; no murmur |
| Musculoskeletal | No spinal or joint tenderness |
| Skin | Compression garments fitting well; no skin irritation |
| Problem | Clinical status | Verification | Code | Provenance |
|---|---|---|---|---|
| Myalgic encephalomyelitis/chronic fatigue syndrome, post-infectious, moderate severity, with orthostatic intolerance; synthetic modern diagnosis by NICE and IOM criteria, linked to her documented Crimean fever and decades of illness, which are only retrospectively and disputedly read as ME/CFS | active | confirmed | G93.32 | S — Synthetic diagnosis made by clinical criteria after exclusion tests in the modern episode; the historical reading of her illness as ME/CFS remains R and disputed. |
| Personal history of brucellosis diagnosed by serology during an overseas field-hospital deployment and treated with six weeks of doxycycline and rifampin; no evidence of relapse | active | confirmed | Z86.19 | S — Synthetic history echoing the disputed retrospective interpretation of her Crimean fever as brucellosis; not a historical diagnosis. |
| Vitamin D deficiency | active | confirmed | E55.9 | S — Synthetic finding on the intake tests, reviewed at the two-week visit. |
Protocol monitoring: items the monitoring protocol calls for at this visit. [S]
| Domain | Measure | Interval | Status | Detail |
|---|---|---|---|---|
| Survey | PHQ-9 mood screen | At diagnosis and at each review | Completed today | 6, down from 8, with item 9 scored 0 |
| Survey | PROMIS fatigue and physical function T-scores, pain score | At diagnosis and at each review | Completed today | Fatigue 67, physical function 35, pain 3 |
| Laboratory | 25-hydroxyvitamin D about three months after starting repletion | Once, about three months after starting | Deferred | Left off today's order in error, a deviation from the plan. She is taking the supplement daily and has no symptoms of excess, so no harm is expected; it will be drawn at the six-month review |
| Examination | Symptom review: post-exertional malaise, sleep, pain, cognition, and orthostatic symptoms | Every review | Completed today | Two crashes in two months; orthostatic symptoms two or three times a week |
| Examination | Ten-minute standing test | Repeat if symptoms change, or at six months | Due | Planned at the six-month review |
| Self-management | Energy management plan review | Every review | Completed today | Small trial increase of 30 minutes of work a day, to be kept only if the diary shows no post-exertional malaise |
| Medication safety | Medication review | Every review | Completed today | Cholecalciferol daily; acetaminophen about once a week |
Goal progress:
Guideline basis: Myalgic encephalomyelitis (or encephalopathy)/chronic fatigue syndrome: diagnosis and management (NICE guideline NG206) (2021); Diagnosing ME/CFS (2024); Grach SL, et al. Diagnosis and Management of Myalgic Encephalomyelitis/Chronic Fatigue Syndrome. Mayo Clin Proc 2023;98(10):1544-1551 (2023)
Follow-up: ME/CFS review in about three months with 25-hydroxyvitamin D, PROMIS scores, PHQ-9, GAD-7, and a repeat standing test. Occupational therapist as needed. Next scheduled visit 2026-09-14: six-month ME/CFS care plan review. [S]